Interpret and explain in simple terms
Here is a plain-language explanation of this PET-CT scan report for Ratilalbhai Patel, 76-year-old male, dated 30 May 2026.
What is a PET-CT Scan?
A PET-CT combines two scans in one. The CT gives detailed pictures of organs and tissues. The PET detects a radioactive sugar (FDG) that cancer cells tend to absorb more than normal cells - so "FDG avid" means a spot is likely metabolically active (possibly cancerous).
Tumour Markers (Blood Tests Done Before the Scan)
| Marker | Patient's Value | What it Means |
|---|---|---|
| AFP (Alpha-fetoprotein) | 876.93 (very high) | Strongly associated with liver cancer (HCC) |
| CEA | 1.9 (normal) | Not elevated |
| PSA | 5.59 (mildly raised) | Prostate marker, slightly high for age |
| LDH | 529 (raised) | General marker of cell damage/cancer |
The markedly raised AFP is the key finding - it strongly points toward liver cancer.
What the Scan Found (Organ by Organ)
Liver (Most Important)
- Multiple tumour spots in both lobes of the liver, actively absorbing sugar (FDG avid), meaning they are likely malignant.
- The largest is about 3.5 x 3.1 cm in segment VI, and another 2.8 x 3.1 cm in segment II.
- Some have dead tissue (necrosis) in the centre - a feature of aggressive tumours.
- The bile duct (CBD) is dilated, suggesting blockage.
Lymph Nodes
- Multiple enlarged, cancerous lymph nodes in the chest and abdomen (around the lungs, liver, pancreas, stomach, aorta).
- This means the cancer has spread to the lymphatic system.
Bones
- Multiple bone lesions scattered widely - both shoulder blades, ribs, spine (neck to lower back), sternum, pelvis, thigh bone.
- Some vertebrae (spinal bones) are partially collapsed (wedging), which can cause back pain and is a risk for spinal cord compression.
Abdomen (Peritoneum)
- Minimal free fluid (ascites) with tumour deposits on the inner lining of the abdomen (peritoneal carcinomatosis) - meaning cancer has seeded the abdominal cavity.
- Omental nodules (deposits on the fatty layer covering the intestines).
Spleen
- A few small, mildly active nodules - likely spread to the spleen.
Lungs
- A few small suspicious nodules in the right lung - possible lung metastases, though they are not strongly FDG avid.
- Small right-sided pleural effusion (fluid around the lung).
Other Incidental (Non-Cancer) Findings
- Enlarged prostate (40 x 39.5 mm) - common in older men, no cancer signal in it.
- Right inguinal hernia (bulge in groin, 37.5 mm).
- Old scarring/fibrosis in lungs - from past infections, not cancer.
- Age-related brain changes and mild spinal arthritis (osteophytes).
The Doctors' Conclusion (Impression)
The most likely diagnosis is:
Metastatic Hepatocellular Carcinoma (HCC) - liver cancer that has spread widely
Specifically, this appears to be multicentric HCC (cancer arising in multiple spots in the liver at the same time) with spread to:
- Lymph nodes
- Bones
- Spleen
- Lungs (likely)
- Abdominal lining (peritoneal carcinomatosis)
A second possibility mentioned is Metastases of Unknown Origin (MUO) - meaning the primary cancer site is not clearly identified. Lymphoma was considered but thought less likely.
A biopsy of the liver lesion was taken during this scan and sent for microscopic analysis (HPE) to confirm the exact cancer type.
In Summary - Simple Terms
The scan shows advanced cancer, most likely starting in the liver, that has spread to the bones, lymph nodes, abdominal lining, spleen, and possibly the lungs. The blood test showing very high AFP (876) strongly supports liver cancer (HCC). A biopsy has been taken to confirm this. This is a serious, advanced-stage finding and the patient will need urgent discussion with an oncologist about treatment options.
Important: This explanation is for informational purposes only. Please consult the treating oncologist (Dr. Ashish Kaushal or a cancer specialist) to understand the next steps, prognosis, and available treatment options for this specific patient.
Treatment
Reading File
Searching PubMed
hepatocellular carcinoma advanced metastatic treatment
Searching the Web
advanced HCC hepatocellular carcinoma treatment guidelines 2025 2026 first line
Finding Sources
Reading Web Page
advanced HCC treatment first line second line systemic therapy 2025
Reading File
Reading File
Here is a thorough, plain-language guide to treatment options for this patient's condition - advanced/metastatic HCC (Hepatocellular Carcinoma), Stage BCLC-C/D, based on current 2025 ESMO guidelines and latest evidence.
Important Context First
This patient's scan shows very advanced (Stage IV) cancer with spread to bones, lymph nodes, abdominal lining, spleen, and possibly lungs. At this stage, cure is not the goal - the goals are:
- Control the cancer and slow its growth
- Relieve symptoms and maintain quality of life
- Prolong survival as much as possible
BCLC Staging (The System Doctors Use)
The Barcelona Clinic Liver Cancer (BCLC) system guides HCC treatment:
| Stage | Description | Treatment |
|---|---|---|
| 0 / A | Early, small tumour | Surgery / Ablation / Transplant (Curative) |
| B | Multiple tumours, confined to liver | TACE (targeted liver procedure) |
| C | Advanced, vascular invasion or spread | Systemic drugs (this patient is here) |
| D | End-stage, very poor function | Supportive/comfort care only |
This patient is BCLC Stage C (advanced), possibly borderline D given the extent of spread.
Treatment Options for This Patient
1. FIRST-LINE SYSTEMIC THERAPY (Main Treatment)
(Given the widespread disease, medicines that work throughout the whole body)
Best Option (if liver function is preserved - Child-Pugh A):
Atezolizumab + Bevacizumab ("Atezo-Bev" / brand: Tecentriq + Avastin)
- This is the #1 recommended combination per ESMO 2025 guidelines (Level I, Grade A)
- Atezolizumab is an immunotherapy (checkpoint inhibitor) - it "unlocks" the immune system to attack cancer cells
- Bevacizumab is an anti-angiogenic drug - it cuts off the blood supply that feeds the tumour
- Given as IV infusion every 3 weeks
- Improves survival compared to older treatments
- Caution: Must screen for bleeding varices (stomach/esophageal veins) before starting, because bevacizumab can cause bleeding
Alternative Option:
Durvalumab + Tremelimumab (brand: Imfinzi + Imjudo)
- Another immunotherapy combination, also Level I, Grade A (ESMO 2025)
- Good alternative if bevacizumab is contraindicated (e.g. bleeding risk)
If immunotherapy is not suitable (e.g. autoimmune disease, poor organ function):
Lenvatinib (brand: Lenvima) - oral tablet daily or Sorafenib (brand: Nexavar) - oral tablet twice daily
- These are older targeted therapy (TKI) drugs - they slow cancer growth by blocking signals tumour cells need to grow
- Both are pills, which is convenient
- Sorafenib was the standard for 10+ years; Lenvatinib is at least as effective with slightly better response rates
2. SECOND-LINE THERAPY (If First Line Stops Working)
Options include:
- Regorafenib (Stivarga) - oral TKI
- Cabozantinib (Cabometyx) - oral TKI
- Ramucirumab - IV, especially if AFP is very high (like this patient - AFP 876)
- Nivolumab + Ipilimumab (Opdivo + Yervoy) - immunotherapy combination
3. BONE METASTASES (Critical for This Patient)
This patient has widespread bone lesions with spinal collapse - this needs specific management:
- Zoledronic acid (Zometa) or Denosumab (Xgeva) - monthly IV/injection to:
- Strengthen bones
- Reduce risk of fractures
- Reduce bone pain
- Radiotherapy (SBRT/palliative radiation) to painful bone spots or at-risk vertebrae
- Orthopaedic consultation for the collapsed vertebrae (L1, D6, D12) - may need a vertebroplasty (cement injection to stabilize spine) or back brace
- Pain management - likely needs strong pain medicines (opioids if needed)
4. ASCITES AND PERITONEAL DISEASE
- The fluid in the abdomen (ascites) can be drained via paracentesis (needle drainage) for symptom relief
- Diuretics (spironolactone + furosemide) to reduce fluid build-up
- Dietary salt restriction
5. PLEURAL EFFUSION (Fluid Around Lung)
- Small right pleural effusion - monitor; may need thoracentesis (draining) if it grows and causes breathlessness
6. AWAITING BIOPSY RESULT (Very Important)
The doctors have done a liver biopsy - this is pending. Why it matters:
- If confirmed as HCC - treatment as above
- If it turns out to be a different cancer type (e.g. cholangiocarcinoma, lymphoma, metastasis from another site) - the treatment would change completely
- Do NOT start systemic treatment without the biopsy result
What About Surgery or Liver Procedures?
- Surgery (resection or transplant): NOT suitable - cancer is too widespread (bones, lymph nodes, peritoneum, lungs)
- TACE (targeted liver artery procedure): Generally not used in this stage because cancer has spread beyond the liver
- Ablation (burning/freezing tumour): Not applicable - too many tumours in multiple organs
Supportive/Palliative Care (Very Important)
Regardless of which cancer treatment is chosen, the following should run alongside it:
- Pain control - proper pain medicine ladder (paracetamol → NSAIDs → opioids as needed)
- Nutritional support - dietician review; cancer and liver disease cause weight loss
- Physiotherapy - for mobility, given bone disease
- Palliative care team referral - specialists in symptom control and quality of life; NOT just "end-of-life" care
- Psychological support for patient and family
Summary Table
| Issue | Recommended Action |
|---|---|
| Liver tumours | Atezolizumab + Bevacizumab (first choice) or Lenvatinib |
| Bone metastases | Zoledronic acid + pain radiotherapy + orthopaedic review |
| Collapsed vertebrae | Spine surgeon consult; vertebroplasty possible |
| Abdominal fluid | Paracentesis + diuretics |
| Lung fluid | Monitor; drain if symptomatic |
| Enlarged prostate | Urology review (separate issue) |
| Confirm diagnosis | Wait for biopsy (HPE) result before starting systemic treatment |
| Symptom relief | Palliative care team alongside oncology |
Next Steps the Family Should Take
- Share this report with a medical oncologist (cancer specialist) urgently
- Wait for the biopsy result (HPE) - expected within 1-2 weeks
- Get a liver function test (Child-Pugh score) done to check if the liver can tolerate treatment
- Ask about bone protection medicines (Zometa/Denosumab) and pain management right away
- Consider a palliative care consultation in parallel - this improves quality of life and does not mean giving up on treatment
Disclaimer: This is an educational explanation based on current guidelines (ESMO 2025, Sabiston Surgery, Bailey & Love Surgery). All treatment decisions must be made by the treating oncologist who knows the full clinical picture, liver function status, and biopsy results.
Is it curable or not
I want to be honest with you, because you deserve a clear answer.
The Honest Answer: No, This is Not Curable
Based on what the scan shows, this cancer is not curable at this stage.
Here is why:
The cancer has spread too far for cure
Cure is only possible when cancer is contained - meaning it can be completely removed or destroyed. In this patient's case, the cancer has spread to:
- Both lobes of the liver (multiple tumours)
- Bones - spine, ribs, pelvis, shoulder blades, thigh bone
- Abdominal lining (peritoneal carcinomatosis)
- Lymph nodes in chest and abdomen
- Spleen
- Possibly lungs
When cancer has spread this widely to multiple organs and bones, no surgery, no ablation, no transplant can remove it all. That window has passed.
What Treatment CAN Do
Even though cure is not possible, treatment still matters greatly:
| Goal | What It Means Practically |
|---|---|
| Control the cancer | Slow its growth, stop it spreading faster |
| Shrink some tumours | Reduce pain and pressure |
| Prolong life | Modern immunotherapy (Atezolizumab + Bevacizumab) can add months to over a year of meaningful life |
| Relieve symptoms | Pain control, draining fluid, protecting bones |
| Maintain dignity | Good palliative care preserves quality of life |
Survival - What the Evidence Says
For advanced HCC (this stage), with modern immunotherapy treatment:
- Median survival is approximately 12 to 20 months from diagnosis with the best current treatments
- Some patients do better, some worse - it depends on liver function, response to treatment, and overall health
- Without treatment, survival is typically 3 to 6 months
- The biopsy result could slightly change this picture if it reveals a different cancer type
One Important Note
The biopsy result is still pending. In rare cases, if the cancer turns out to be something like lymphoma, it could actually be treatable with chemotherapy and outcomes could be better. The doctors listed lymphoma as "less likely" but not impossible. So the biopsy matters.
What This Means for the Family
This is a very difficult time. The focus now should be on:
- Quality of life - keeping the patient as comfortable and pain-free as possible
- Time with family - this is precious and should not all be spent in hospitals
- Honest conversations with the oncologist about realistic goals of treatment
- Palliative care - specialized doctors who focus on comfort, pain, and dignity alongside any cancer treatment
- The patient's own wishes - what does he want? Some patients want to fight with every treatment available; others prefer comfort over treatment side effects. Both are valid.
I am deeply sorry for what your family is going through. If you have more questions - about what to expect, how to manage symptoms, or how to talk to the doctors - please ask. I am here to help.
This is a shared conversation. Sign in to Orris to start your own chat.